While some individual ingredients, such as berberine, have modest evidence of weight loss when taken orally at therapeutic doses, there is no evidence that meaningful amounts can be delivered through skin patches
Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease
GutBrain Axis 101: Serotonin, 5HTP & Digestive Signaling Why 90 % of Serotonin Lives in Your Gut GLP-1s affect more than your gut
While GLP-1 receptor agonists like semaglutide help with weight loss, new research shows users often fall short on vital nutrients, spotlighting the urgent need for tailored dietary guidance
No financial access to FeelGood's internal patient outcome data was obtained
Diarrhoea may occur in some people